Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023/24 season.

Authors:
Smolarchuk C; Ickert C; Zelyas N; Kwong JC; Buchan SA.

Journal:
Euro Surveill

Publication Year: 2024

DOI:
10.2807/1560-7917.ES.2024.29.2.2300709

PMCID:
PMC10785209

PMID:
38214082

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Euro Surveill

Abbreviation: Euro Surveill

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case of swine influenza A(H1N2)v in England, November 2023.
Cogdale J; Kele B; Myers R and 24 more (2024) - Transparency Score: 3/6
Application of the screening method for estimating COVID-19 vaccine effectiveness using routine sur…
Perumal N; Schönfeld V; Wichmann O. (2024) - Transparency Score: 5/6
Author's correction for Euro Surveill. 2024;29(2).
Eurosurveillance editorial team. (2024) - Transparency Score: 1/6
Authors' correction for Euro Surveill. 2024;29(3).
Eurosurveillance editorial team. (2024) - Transparency Score: 1/6
Clinical isolates of ST131 <i>bla</i>OXA-244-positive <i>Escherichia coli</i>, Italy, December 2022…
Piazza A; Corbella M; Mattioni Marchetti V and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: None declared."

Evidence found in paper:

"Funding statement Undertaken as part of Government of Alberta-funded public health surveillance."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025